期刊文献+

多重耐药阴沟肠杆菌β-内酰胺酶编码基因的研究 被引量:19

β-Lactamase-encoding Genes of Multiple-drug-resistant Enterobacter cloacae
暂未订购
导出
摘要 目的 了解北京朝阳医院临床分离的多重耐药阴沟肠杆菌的 β-内酰胺酶编码基因。方法 对 12株临床分离的多重耐药的阴沟肠杆菌进行琼脂稀释法药敏试验、改良三维试验法和聚合酶链反应克隆测序。结果  12株阴沟肠杆菌对多种抗生素耐药 ,改良三维试验法证实同时产生 Am p C酶和 ESBL s;其中 ,9株 ESBL s编码基因PCR结果阳性 ,分别为 SHV- 2、SHV- 12、CTX- M- 3和 CTX- M- 14型 ESBL s;对另外 3株进行粗酶等电点测定发现 ,存在 7.89和 8.0等电点条带 ,并被克拉维酸抑制 ;12株细菌 am p D和 amp C基因 PCR扩增均呈阳性 ,将 6株耐药菌进行 amp D基因的克隆测序发现均存在羧基端可疑的突变位点。结论  12株多重耐药的阴沟肠杆菌同时产生≥ 1种的 ESBL s及高产 Am p C酶。 OBJECTIVE To investigate the β-lactamase-encoding genes of Enterobacter cloacae isolated in Beijing Chaoyang Hospital. METHODS Standard agar dilution method,improved three-dimensional tests,PCR amplification,gene cloning and DNA sequencings were performed in the 12 strains of E. cloacae resistant to many antibiotics. RESULTS Twelve strains of E. cloacae were multiple-drug-resistant and proved to produce AmpC β-lactamase and ESBLs by improved three-dimensional tests. DNA sequences of 9 strains of E. cloacae revealed ESBLs of SHV-2,SHV-12,CTX-M-3,CTX-M-14 and β-lactamase of TEM-1 and SHV-11. The other three strains produced unidentified enzymes with pI 7.89 and 8.0 which were inhibited by cloxacillin. The ampD gene sequencing results of 6 strains showed that there were amino acid substitutions in the carboxy-terminal of AmpD. CONCLUSIONS Twelve strains of E. cloacae produced AmpC β-lactamase and one or more types of ESBLs.
出处 《中华医院感染学杂志》 CAS CSCD 2004年第5期481-484,共4页 Chinese Journal of Nosocomiology
基金 国家自然科学基金 (30 2 70 0 74 )
关键词 阴沟肠杆菌 AMPC酶 ESBLS 聚合酶链反应 基因 Enterobacter cloacae AmpC beta-lactamase Extended-spectrum β-lactamases (ESBLs) Polymerase chain reaction Gene
  • 相关文献

参考文献11

二级参考文献37

  • 1Pitout JDD, Moland ES, Sander CC, et al. β-Lactamases and detection of β-lactam resistance in Enterobacter spp[J]. Antimicrob Agents Chemother, 1997,41 :35-39.
  • 2Ehrhardt AF,Sanders CC,Romero JR, et al. Sequencing and analysis of four new Enterobacter ampD genes of Cirtrobacter freundii and Enterobacter cloacae [ J ]. Antimicrob Agents Chemother, 1996,40:1953-1956.
  • 3Pitout JD, Sanders CC, Sanders WE. Antimicrobial resistance with focus on β-Lactam resistance in Gram-negative bacilli[J]. Am J Med,1997,103: 51-59
  • 4Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae[J]. Clin Infect Dis, 1998, 27(Suppl 1):s100-s106
  • 5Livermore DM. β-lactamases in laboratory and clinical resistance[J]. Clin Microb Rev, 1995,8:557-584
  • 6Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery?[J] Yonsei Med J, 1998, 39:520-525
  • 7Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamase among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microb, 2000, 38:1791-1796
  • 8National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing[S]; ninth informational supplement (M100-S9). NCCLS, Wayne, Pennsylvania, 1999
  • 9Mathew MJ, Harris AM, Marshall A, et al. The use of analytical isoelectric focusing for detection and identification of β-lactamases[J]. J Gen Microbiol, 1975,88:169-178
  • 10Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual [M]. 2nd ed, Cold Spring Harbor Laboratory Press

共引文献421

同被引文献105

引证文献19

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部